These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35285475)

  • 21. Identification of metabolites and potential biomarkers of kratom in urine.
    Basiliere S; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121971. PubMed ID: 32058315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine.
    Papsun DM; Chan-Hosokawa A; Friederich L; Brower J; Graf K; Logan B
    J Anal Toxicol; 2019 Sep; 43(8):615-629. PubMed ID: 31424079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PCR combined with lateral flow immunochromatographic assay to differentiate the narcotic Mitragyna speciosa from related species and detect it in forensic evidence.
    Tungphatthong C; Phadungcharoen T; Sooksawate T; Sukrong S
    Forensic Sci Int; 2022 Feb; 331():111149. PubMed ID: 34933184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
    Basiliere S; Kerrigan S
    J Anal Toxicol; 2020 May; 44(4):301-313. PubMed ID: 32008041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum.
    Horie S; Koyama F; Takayama H; Ishikawa H; Aimi N; Ponglux D; Matsumoto K; Murayama T
    Planta Med; 2005 Mar; 71(3):231-6. PubMed ID: 15770543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal Mitragynine-Associated Toxicity in Canada: A Case Report and Review of the Literature.
    Wang C; Walker AE
    Acad Forensic Pathol; 2018 Jun; 8(2):340-346. PubMed ID: 31240047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug testing for mitragynine and kratom: Analytical challenges and medico-legal considerations.
    Helander A; Rylski A
    Drug Test Anal; 2023 Feb; 15(2):213-219. PubMed ID: 36258649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity.
    Adkins JE; Boyer EW; McCurdy CR
    Curr Top Med Chem; 2011; 11(9):1165-75. PubMed ID: 21050173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of Mitragynine in
    Mudge EM; Brown PN
    J AOAC Int; 2017 Jan; 100(1):18-24. PubMed ID: 27725074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
    Lesiak AD; Cody RB; Dane AJ; Musah RA
    Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitation of mitragynine biosynthesis in Mitragyna speciosa (Roxb.) Korth. through tryptamine availability.
    Charoonratanaa T; Wungsintaweekul J; Pathompak P; Georgiev MI; Choi YH; Verpoorte R
    Z Naturforsch C J Biosci; 2013; 68(9-10):394-405. PubMed ID: 24459773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
    Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
    Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia.
    Singh D; Müller CP; Murugaiyah V; Hamid SBS; Vicknasingam BK; Avery B; Chear NJY; Mansor SM
    J Ethnopharmacol; 2018 Mar; 214():197-206. PubMed ID: 29248450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder.
    Huestis MA; Brett MA; Bothmer J; Atallah R
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of alkaloid-rich extract from Mitragyna speciosa (Korth.) Havil. on naloxone-precipitated morphine withdrawal symptoms and local field potential in the nucleus accumbens of mice.
    Cheaha D; Reakkamnuan C; Nukitram J; Chittrakarn S; Phukpattaranont P; Keawpradub N; Kumarnsit E
    J Ethnopharmacol; 2017 Aug; 208():129-137. PubMed ID: 28687506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats.
    Sabetghadam A; Ramanathan S; Sasidharan S; Mansor SM
    J Ethnopharmacol; 2013 Apr; 146(3):815-23. PubMed ID: 23422336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats.
    Yusoff NHM; Mansor SM; Müller CP; Hassan Z
    Behav Brain Res; 2017 Aug; 332():1-6. PubMed ID: 28559179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review.
    Ya K; Tangamornsuksan W; Scholfield CN; Methaneethorn J; Lohitnavy M
    Asian J Psychiatr; 2019 Jun; 43():73-82. PubMed ID: 31100603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats.
    Hassan R; Othman N; Mansor SM; Müller CP; Hassan Z
    Brain Res Bull; 2021 Jul; 172():139-150. PubMed ID: 33901587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
    Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
    Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.